Advanced Enzyme Technologies Ltd
Thu 13/03/2025,15:59:6 | NSE : ADVENZYMES
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 268.05
Previous Close
₹ 267.60
Volume
277055
Mkt Cap ( Rs. Cr)
₹2987.21
High
₹ 278.40
Low
₹ 265.35
52 Week High
₹ 571.00
52 Week Low
₹ 257.90
Book Value Per Share
₹ 119.92
Dividend Yield
0.41
Face Value
₹ 2.00
What’s Your Call?
Collective community sentiment on Advanced Enzyme Technologies Ltd
Your Vote -
Buy
94.70%
Hold
0.59%
Sell
4.72%
94.70%
1018 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
100%
Sell Order Quantity
0%
Bid Price
Qty
267.00
150
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
150
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Option Chain
Analyzes market sentiment, predicts Advanced Enzyme Technologies Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Advanced Enzyme Tech - Analysts/Institutional Investor Meet/Con. Call Updates
-
Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Advanced Enzyme Tech - Analysts/Institutional Investor Meet/Con. Call Updates
-
Advanced Enzyme Tech - Analysts/Institutional Investor Meet/Con. Call Updates
-
Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Advanced Enzyme Tech - Analysts/Institutional Investor Meet/Con. Call Updates
-
Advanced Enzyme Tech - Credit Rating
-
Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Credit Rating
-
Advanced Enzyme Tech - Analysts/Institutional Investor Meet/Con. Call Updates
-
Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
-
Advanced Enzyme Tech - Analysts/Institutional Investor Meet/Con. Call Updates
-
Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
-
Advanced Enzyme Tech - Copy of Newspaper Publication
-
Advanced Enzyme Tech - Integrated Filing- Financial
-
Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Investor Presentation
-
Advanced Enzyme Tech - Investor Presentation
-
Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Advanced Enzyme Tech - Press Release
-
Advanced Enzyme Tech - Outcome of Board Meeting
-
Advanced Enzyme Tech - Financial Result Updates
-
Advanced Enzyme Tech Q3 net profit down 20.61% at Rs 15.18 cr
-
Advanced Enzyme Tech - Unaudited Financial Results (Standalone & Consolidated) Of The Company For The Quarter And Nine Months
-
Advanced Enzyme Tech - Board Meeting Outcome for Outcome Of Board Meeting Held On February 08, 2025
-
Advanced Enzyme Tech - Analysts/Institutional Investor Meet/Con. Call Updates
-
Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Advanced Enzyme Tech - Board Meeting Intimation
-
Advanced Enzyme Tech has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2024
-
Advanced Enzyme Tech - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Advanced Enzyme Tech - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Advanced Enzyme Tech - Analysts/Institutional Investor Meet/Con. Call Updates
-
Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Advanced Enzyme Tech - Trading Window
-
Advanced Enzyme Tech - Trading Window-XBRL
-
Advanced Enzyme Tech - Update-Acquisition/Scheme/Sale/Disposal-XBRL
-
Advanced Enzyme Tech - General Updates
-
Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Updates on Acquisition
-
Advanced Enzyme Tech - Analysts/Institutional Investor Meet/Con. Call Updates
-
Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Advanced Enzymes announces positive clinical breakthrough
-
Advanced Enzymes
-
Advanced Enzyme hits 52-week high
Key fundamentals
Evaluate the intrinsic value of Advanced Enzyme Technologies Ltd stock
Name | March-24 | March-23 | March-22 | March-21 | March-20 |
---|---|---|---|---|---|
Assets | 580.471 | 525.339 | 480.528 | 435.763 | 379.107 |
Liabilities | 580.471 | 525.339 | 480.528 | 435.763 | 379.107 |
Equity | 22.365 | 22.365 | 22.36 | 22.346 | 22.336 |
Gross Profit | 105.186 | 74.888 | 72.648 | 100.621 | 76.766 |
Net Profit | 108.123 | 55.527 | 54.511 | 71.012 | 57.955 |
Cash From Operating Activities | 55.81 | 50.296 | 37.102 | 84.192 | 45.976 |
NPM(%) | 29.58 | 17.82 | 19.98 | 25.05 | 23.42 |
Revenue | 365.469 | 311.529 | 272.798 | 283.473 | 247.354 |
Expenses | 260.283 | 236.641 | 200.15 | 182.852 | 170.588 |
ROE(%) | 8.05 | 4.13 | 4.06 | 5.29 | 4.31 |
Corporate Action
XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
---|---|---|---|---|
18 Jul 2024 | 1.1 | 55 | 0.41 | 398.65 |
04 Aug 2023 | 1 | 50 | 0.41 | 284.65 |
11 Aug 2022 | 1 | 50 | 0.41 | 277.85 |
31 Aug 2021 | 0.9 | 45 | 0.41 | 427.85 |
09 Jul 2020 | 0.6 | 30 | 0.41 | 149.9 |
01 Aug 2019 | 0.6 | 30 | 0.41 | 200.85 |
06 Sep 2018 | 0.5 | 25 | 0.41 | 221.4 |
04 Sep 2017 | 0.4 | 20 | 0.41 | 362.4 |
Peers
Other companies within the same industry or sector that are comparable to Advanced Enzyme Technologies Ltd
Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
---|---|---|---|---|---|---|
Sameera Agro And Infra Ltd | 56.60 | -3.33 | 7.72 | 317.81 | 90.02 | 0.00 |
Shreeoswal Seeds and Chemicals Ltd | 15.28 | -0.39 | 0.00 | 2440.88 | -22.75 | 0.00 |
GRM Overseas Ltd | 273.21 | 1.01 | 26.47 | 1601.10 | 498.18 | 0.00 |
Jain Irrigation Systems Ltd | 55.90 | -0.80 | 0.00 | 18326.19 | 33.67 | 0.00 |
Company Info
The Company was incorporated, as a private limited company on March 15, 1989 under the provisions of the Companies Act, 1956 as Advanced Biochemicals Private Limited in Maharashtra. Pursuant to a special resolution passed by the shareholders of the Company at the extra-ordinary general meeting held on April 21, 1992, the Company was converted into a public limited company and consequently the name of the Company was changed to Advanced Biochemicals Limited. A fresh certificate of incorporation reflecting the new name was issued by the Registrar of Companies, Maharashtra on May 28, 1992. Pursuant to a special resolution passed by the shareholders of the Company at the extraordinary general meeting held on August 8, 2005, the name of the Company was further changed from Advanced Biochemicals Limited to Advanced Enzyme Technologies Limited. A fresh certificate of incorporation reflecting the new name was issued by the Registrar of Companies, Maharashtra, Mumbai on August 19, 2005. Major events in the History of the Company 1989 - Incorporation as Advanced Biochemicals Private Limited. 1992 - Conversion from private company into a public company and renamed as Advanced Biochemicals Limited. 1994 - Commissioning of the first fermentation facility at Sinnar, Maharashtra 2001 - Recognition of in-house R&D centers of the Company at Thane and Sinnar by the Department of Scientific and Industrial Research, Ministry of Science and Technology, Government of India. 2005 - Change of name of the Company from Advanced Biochemicals Limited to Advanced Enzyme Technologies Limited. 2011 - Takeover of Cal-India Foods International (Specialty Enzymes and Biotechnologies) by the Company giving us direct presence in USA. 2012 - Kotak India Venture Fund I, Kotak Employees Investment Trust and Kotak India Venture (Offshore) Fund made an investment in the Company. 2012 - Takeover of AST Enzymes by the Company for consolidating the presence in USA. Awards and accreditations received by the Company 2010 - The Company won the "Emerging India Awards" for 2010 in the Life Science -Pharmaceuticals & Chemicals segment organized by ICICI Business Banking and CNBC TV18.2010 - The Company won the Bio Excellence Award in the Industrial Biotech category for 2010 instituted by Department of Information Technology, Biotechnology and Science and Technology, Government of Karnataka.2012 - The Company was awarded as the 1st runner-up for the Most Innovative Exporter - Dun & Bradstreet for the year 2012. 2013 - The Company was one of the Recipients of the fastest growing mid-sized business award organized by Inc. India. 2014 - The Company received the Bio Excellence Award in the Industrial Biotech category for year 2014 instituted by Department of Information Technology, Biotechnology and Science and Technology,Government of Karnataka. 2016 -Advanced Enzyme Technologies are listed and admitted to dealings on the Exchange in the list of 'B' Group Securities. - "Advanced Enzymes acquires 70% stake in API maker JC Biotech". - Advanced Enzyme Technologies has been awarded by ABP News for being "The Best Nutraceutical Company of the Year". 2017 -The Company has been awarded for 'BEST IPO' at IR Society Awards 2017. -Acquired 100% stake in a German based company evoxx technologies GmbH. 2018 -Acquired 100% stake in SciTech Specialties Private Limited. 2023 -Advanced Enzyme Technologies Limited has informed the Exchange regarding 'Update on acquisition of 50% stake in Saiganesh Enzytech Solutions Private Limited;and an additional 4.83% of JC Biotech Private Limited. 2024 -Advanced Enzyme Technologies Limited has informed the acquisition of additional stake of 5.89% in JC Biotech Private Limited.
The Company was incorporated, as a private limited company on March 15, 1989 under the provisions of the Companies Act, 1956 as Advanced Biochemicals Private Limited in Maharashtra. Pursuant to a special resolution passed by the shareholders of the Company at the extra-ordinary general meeting held on April 21, 1992, the Company was converted into a public limited company and consequently the name of the Company was changed to Advanced Biochemicals Limited. A fresh certificate of incorporation reflecting the new name was issued by the Registrar of Companies, Maharashtra on May 28, 1992. Pursuant to a special resolution passed by the shareholders of the Company at the extraordinary general meeting held on August 8, 2005, the name of the Company was further changed from Advanced Biochemicals Limited to Advanced Enzyme Technologies Limited. A fresh certificate of incorporation reflecting the new name was issued by the Registrar of Companies, Maharashtra, Mumbai on August 19, 2005. Major events in the History of the Company 1989 - Incorporation as Advanced Biochemicals Private Limited. 1992 - Conversion from private company into a public company and renamed as Advanced Biochemicals Limited. 1994 - Commissioning of the first fermentation facility at Sinnar, Maharashtra 2001 - Recognition of in-house R&D centers of the Company at Thane and Sinnar by the Department of Scientific and Industrial Research, Ministry of Science and Technology, Government of India. 2005 - Change of name of the Company from Advanced Biochemicals Limited to Advanced Enzyme Technologies Limited. 2011 - Takeover of Cal-India Foods International (Specialty Enzymes and Biotechnologies) by the Company giving us direct presence in USA. 2012 - Kotak India Venture Fund I, Kotak Employees Investment Trust and Kotak India Venture (Offshore) Fund made an investment in the Company. 2012 - Takeover of AST Enzymes by the Company for consolidating the presence in USA. Awards and accreditations received by the Company 2010 - The Company won the "Emerging India Awards" for 2010 in the Life Science -Pharmaceuticals & Chemicals segment organized by ICICI Business Banking and CNBC TV18.2010 - The Company won the Bio Excellence Award in the Industrial Biotech category for 2010 instituted by Department of Information Technology, Biotechnology and Science and Technology, Government of Karnataka.2012 - The Company was awarded as the 1st runner-up for the Most Innovative Exporter - Dun & Bradstreet for the year 2012. 2013 - The Company was one of the Recipients of the fastest growing mid-sized business award organized by Inc. India. 2014 - The Company received the Bio Excellence Award in the Industrial Biotech category for year 2014 instituted by Department of Information Technology, Biotechnology and Science and Technology,Government of Karnataka. 2016 -Advanced Enzyme Technologies are listed and admitted to dealings on the Exchange in the list of 'B' Group Securities. - "Advanced Enzymes acquires 70% stake in API maker JC Biotech". - Advanced Enzyme Technologies has been awarded by ABP News for being "The Best Nutraceutical Company of the Year". 2017 -The Company has been awarded for 'BEST IPO' at IR Society Awards 2017. -Acquired 100% stake in a German based company evoxx technologies GmbH. 2018 -Acquired 100% stake in SciTech Specialties Private Limited. 2023 -Advanced Enzyme Technologies Limited has informed the Exchange regarding 'Update on acquisition of 50% stake in Saiganesh Enzytech Solutions Private Limited;and an additional 4.83% of JC Biotech Private Limited. 2024 -Advanced Enzyme Technologies Limited has informed the acquisition of additional stake of 5.89% in JC Biotech Private Limited.
Read More
Parent Organisation
Advanced Enzyme Technologies Ltd.
Founded
15/03/1989
Managing Director
NSE Symbol
ADVENZYMESEQ
FAQ
The current price of Advanced Enzyme Technologies Ltd is ₹ 267.00.
The 52-week high for Advanced Enzyme Technologies Ltd is ₹ 278.40 and the 52-week low is ₹ 265.35.
The market capitalization of Advanced Enzyme Technologies Ltd is currently ₹ 2987.21. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Advanced Enzyme Technologies Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Advanced Enzyme Technologies Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Advanced Enzyme Technologies Ltd shares.
The CEO of Advanced Enzyme Technologies Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.